Skip to main content

Table 1 Patients demographics

From: Efficacy and tolerability of preservative-free 0.0015% tafluprost in glaucoma patients: a prospective crossover study

  Total (n = 20) Group 1 (n = 10) Group 2 (n = 10) p
Age (years) 55.26 ± 14.22a 55.90 ± 15.98a 54.55 ± 12.90a 0.73
Sex (M:F) 10:10 5:5 5:5 1.00
Systemic disease (DM) 2 1 1 1.00
Systemic disease (Hypertension) 9 5 4 0.52
Smoking history 3 2 1 0.06
Laterality (R:L) 8:12 5:5 3:7 0.20
  1. DM diabetes mellitus
  2. aaverage ± standard deviation; p, p-values; chi-square test